Palatin Technologies (PTN) Restructuring Costs (2015 - 2016)
Palatin Technologies' (PTN) quarterly Restructuring Costs came in at $6514.0 in Q1 2016, up 6.0% on a YoY basis from $6145.0 in Q2 2015, and up 6.0% quarter-over-quarter from $6145.0 in Q1 2015.
Powered by 
Analysis
Palatin Technologies (PTN) Restructuring Costs (2015 - 2016) Analysis & Trends
Palatin Technologies (PTN) has reported Restructuring Costs for 2 consecutive years, with $6514.0 the latest figure, recorded in Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - |